http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8775236

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
issn 2162-402X
issueIdentifier 1
pageRange e1249558-
publicationName OncoImmunology
startingPage e1249558
bibliographicCitation Su S, Zou Z, Chen F, Ding N, Du J, Shao J, Li L, Fu Y, Hu B, Yang Y, Sha H, Meng F, Wei J, Huang X, Liu B. CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer. OncoImmunology. 2016 Nov 22;6(1):e1249558. doi: 10.1080/2162402x.2016.1249558.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89baf9bc30b61b3ef80a784965dd4543
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d184ed4a58563766485dc532b92890f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f97e49f5bd1fef11e6f8e241704dbe6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2eec9baab8160f4a72ce8e87d8eebae
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a67b23d886033c8c0b9356191dd3d19
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40c6d3601c29f574746d1021e592c4c2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f29cee2c9275f83585f1121a51c02954
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13d225e0044c29c57db189ab61cbc62d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be625f4a216db5197aec361845b98249
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_738fc2df0160328b0854fe70e4f5811a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_afbae19b0999cf4f0ed995db074711cd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_258e138498f23be563b0312924663e72
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_596fcdb91152902e98610f7082924a50
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17d010888b6c5f7faa69d196c6681c10
date 2016-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1080/2162402x.2016.1249558
https://pubmed.ncbi.nlm.nih.gov/PMC5283615
https://pubmed.ncbi.nlm.nih.gov/28197365
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39616
https://portal.issn.org/resource/ISSN/2162-402X
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b83d04d3e3b05ce10d1a5893dc850a9b
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9305
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7a0153350cba31da4ce6bfa8f8c68f72

Total number of triples: 37.